Cervical Cancer Screening in Immunocompromised Women

J Obstet Gynaecol Can. 2019 Aug;41(8):1177-1180. doi: 10.1016/j.jogc.2019.03.005. Epub 2019 Jun 22.

Abstract

In the context of changing recommendations for cervical cancer screening, differing recommendations in each province, and a lack of guidance for cervical screening of immunocompromised women, this article provides specific recommendations for cervical cancer screening of immunocompromised women in Canada.

Keywords: Cervical cancer; HIV; cervical screening; cytology; immunocompromised; transplant recipients; women.

MeSH terms

  • Canada / epidemiology
  • Early Detection of Cancer*
  • Evidence-Based Medicine
  • Female
  • HIV Infections / epidemiology
  • HIV Infections / immunology
  • Humans
  • Immunocompromised Host*
  • Mass Screening*
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / immunology*
  • Practice Guidelines as Topic
  • Prevalence
  • Transplantation Immunology
  • Uterine Cervical Neoplasms / diagnosis*
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / immunology*